Trial ID:
IRB-25-8600
Wesleigh Fowler Edwards, MD PhD

Inclusion Criteria

Patients must:

  • Be 18 years or older
    Have a HER2-expressing solid tumor
    Have received at least 2 lines of standard therapy

Exclusion Criteria

Patients must not:

  • Have a history of severe heart disease
    Have active autoimmune diseases
    Have prior malignancies
    Have known or suspected human immunodeficiency virus infection
    Be pregnant or breastfeeding

Additional Info

All treatments and physician visits during the study will take place at Prebys Cancer Center at Mercy Hillcrest.

For more information search NCT#: 06293898 at www.clinicaltrials.gov

Contact Info:

  • Clinical Research Services
  • crsleadership@scrippshealth.org